Bridging the Sciences: Zika Virus
Meeting Overview
On behalf of Raymond Schinazi, PhD, DSc; José Esparza, MD, PhD; and Mauro Teixeira, MD, PhD, course directors and co-chairs, we are pleased to invite you to Bridging the Sciences: Zika Virus, to be held in Atlanta, Georgia, on May 1 – 3, 2016.
This meeting will facilitate interactions and collaboration between Brazilian scientists and their international colleagues, and will feature scientific sessions geared toward fundamental understanding of Zika biology and practical considerations for management of the infection. Participants in this activity will be updated on key features of Zika epidemiology, pathophysiology, and virology, as well as emerging preventive and therapeutic strategies. These updates on basic and clinical research will be presented in a practical and interactive format that facilitates discussion.
Organizing Committee
Course Directors and Co-Chairs
Raymond F. Schinazi, PhD, DSc, Emory University, Global Virus Network, United States
José Esparza, MD, PhD, President, Global Virus Network, United States
Mauro Teixeira, MD, PhD, Universidade Federal de Minas Gerais, Brazil
Scientific Advisory Board:
Robert Gallo, MD, Institute of Human Virology, University of Maryland School of Medicine, Global Virus Network, United States
Glaucius Oliva, PhD, University of São Paulo, Brazil
Mario Stevenson, PhD, University of Miami, Miller School of Medicine, Global Virus Network, United States
David Watkins, PhD, University of Miami, Miller School of Medicine, Global Virus Network, United States
Scott Weaver, MS, PhD, University of Texas Medical Branch, Galveston Laboratory, Global Virus Network , United States
Local Organizing Committee:
Rafi Ahmed, PhD, Emory University, United States
Leda Bassit, PhD, Emory University, United States
Rana Chakraborty, MD, Emory University, United States
Carlos del Rio, MD, Emory University, United States
Christina Gavegnano, PhD, Emory University, United States
Mark Mulligan, MD, Emory University, United States
Guido Silvestri, MD, Emory University, United States
Paul Spearman, MD, Emory University, United States
Mehul Suthar, PhD, Emory Vaccine Center, United States
Administration:
Ann Findley, Emory University, United States
Kelly Johnson, MBA, Emory University, United States
PLATO Foundation and Informed Horizons, LLC
Topics of Discussion
- Epidemiology and pathophysiology of Zika virus, including recent findings from the outbreak
- Insights into diagnosis of Zika virus
- Models for studying Zika virus
- Current approaches to control spread
- Emerging antiviral agents directed at Zika virus
- Recent findings in vaccine development
Target Audience
This program is designed to meet the educational needs of immunologists, embryologists, epidemiologists, obstetricians, virologists, nurses, and other professionals involved in the study and management of Zika virus infection.
Learning Objectives
After successful completion of this educational activity, participants should be able to:
- Describe the current understanding of Zika virus epidemiology, manifestation, and pathophysiology
- Identify current and emerging strategies to minimize spread and impact of Zika virus infection
- Assess the preliminary findings from ongoing clinical trials investigating antiviral agents and vaccines for ZIka virus
Registration Information and Fees
The organizing committee strongly suggests that you register early to ensure your attendance, as registration will close when the capacity of the venue is reached.
Attendee Registration Fee
Registration fee includes the following:
- Entrance into all scientific sessions
- Abstract book and final program
- Welcome reception following the opening session on Sunday
- Continental breakfast, refreshment breaks, lunch, and closing cocktail hour on Monday
- Accommodations, if applicable, at the Emory Conference Center Hotel (limited space available)
Regular Registration (extended through Friday, April 22)
Conference only | Conference and 1 night hotel |
Conference and 2 nights hotel |
|
Attendees | $460 | $650 | $840 |
Students/Fellows | $360 | $550 | $740 |
Industry | $560 | $750 | $940 |
Late Registration (after Friday, April 22)
Conference only | Conference and 1 night hotel |
Conference and 2 nights hotel |
|
Attendees | $560 | $750 | $940 |
Students/Fellows | $460 | $650 | $840 |
Industry | $660 | $850 | $1040 |
Accommodations will be reserved on a first come, first served basis at the conference venue.
Emory Conference Center Hotel
1615 Clifton Road NE
Atlanta, Georgia 30329
Main Number: +1 404.712.6000
For additional information contact Jaye Harden, Jaye.Harden@prIMEoncology.org or 678.892.1353.
Cancellation Policies
Conference Fees Only: Please note that cancellation of registrations received on or before April 18, 2016, will incur a $75 administration fee. Cancellation of registrations received after April 18, 2016, and on or before April 28, 2016, will incur a fee equivalent to 50% of the registration payment. No refund of the registration payment will be issued for cancellations received after April 28, 2016.
Hotel Room Reservations: Hotel rooms cancelled prior to April 10, 2016, are fully refundable. Any cancellations on or after April 10 will not be refunded unless the conference is able to resell the room. Every effort will be made, but this cannot be guaranteed.
Faculty & Agenda
Plenary Speakers
-
José Esparza, MD, PhD
Global Virus Network
Baltimore, Maryland, United States
-
Mauro Martins Teixeira, PhD
Universidade Federal de Minas Gerais
Belo Horizonte, Brazil
-
Maria Van Kerkhove, PhD
Pasteur Institute
Paris, France
-
David Watkins, PhD
University of Miami
Miami, Florida, United States
-
Scott Weaver, MS, PhD
University of Texas Medical Branch
Galveston, Texas, United States
Confirmed Speakers
-
Bryan Cox, PhD
Emory University
Atlanta, Georgia, United States
-
Jorge Kalil, MD, PhD
Instituto Butantan
São Paulo, Brazil
-
Emma Mohr, MD
University of Wisconsin
Madison, Wisconsin, United States
-
Glaucius Oliva, PhD
University of São Paulo Institute of Physics of São Carlos
São Paulo, Brazil
-
Rosana Richtmann, MD, PhD
Emilio Ribas Institute of Infectious Diseases
São Paulo, Brazil
-
Mehul Suthar, PhD
Emory Vaccine Center
Atlanta, Georgia, United States
-
Amilcar Tanuri, MD, PhD
Universidade Federal de Rio de Janeiro
Rio de Janeiro, Brazil
-
Timothy Tellinghuisen, PhD
Scripps Research Institute
Jupiter, Florida, United States
-
Pedro F. C. Vasconcelos, MD
Instituto Evandro Chagas
Ananindeua, Pará, Brazil
-
Gonzalo Vazquez-Prokopec, PhD
Emory University
Atlanta, Georgia, United States
-
Paul Root Wolpe, PhD
Emory University
Atlanta, Georgia, United States
Other Confirmed Faculty
-
Baek Kim, PhD
Emory University
Atlanta, Georgia, United States
-
Suzane Kioko Ono, MD, PhD
University of São Paulo
São Paulo, Brazil
-
Carlos del Rio, MD
Emory University
Atlanta, Georgia, United States
-
Raymond F. Schinazi, PhD, DSc
Emory University
Atlanta, Georgia, United States
-
Mario Stevenson, PhD
University of Miami
Miami, Florida, United States
-
Paolo Marinho de Andrade Zanotto, PhD
University of São Paulo, Institute of Biomedical Sciences
São Paulo, Brazil
Agenda
Sunday, May 1, 2016
AFTERNOON SESSION
Opening Remarks
Raymond F. Schinazi, PhD, DSc
EPIDEMIOLOGY, MANIFESTATIONS, & ETHICS SESSION
Chairs:
Glaucius Oliva, PhD
Raymond F. Schinazi, PhD, DSc
State-of-the-Art Lecture:
Zika in the Broader Context of Other Emerging Viral Epidemics
José Esparza, MD, PhD
Zika Virus Epidemic in Brazil: Present Situation and Perspectives
Pedro F. C. Vasconcelos, MD
Real-Time Experience of Management of Clinical Cases With Zika Infection From Endemic States Seeking Treatment at One of the Largest Infectious Diseases Hospitals in Brazil
Rosana Richtmann, MD, PhD
How Zika Is Challenging Global Health Ethics
Paul Root Wolpe, PhD
Round Table Discussion
All Faculty Above
WELCOME RECEPTION
Monday, May 2, 2016
VIROLOGY, PATHOLOGY, & ANIMAL MODELS SESSION
Chairs:
Suzane Kioko Ono, MD, PhD
Mario Stevenson, PhD
State-of-the-Art Lecture:
Approaches to Manage and Control Zika Virus Infections
Scott Weaver, MS, PhD
Working Toward a Zika Virus Replicon System and Infectious Clone
Timothy Tellinghuisen, PhD
Structural Insights Into Zika Virus Proteins
Glaucius Oliva, PhD
Animal Models for Zika Virus
Emma Mohr, MD
State-of-the-Art Lecture:
Link Between Zika, Guillain-Barré Syndrome, and Microencephaly
Maria Van Kerkhove, PhD
Late Breaker Talks
Zika Virus: Accelerating Development of Medical Countermeasures by Re-purposing Licensed Drugs
Robert Malone, MD, Atheric Pharmaceutical
Zika Virus in an HIV-Infected Cohort in Ghana
Kenneth Sherman, MD, PhD, University of Cincinnati
Development of a Zika Virus Polymerase Assay to Aid in the Identification of a Ribonucleoside Zika Virus Polymerase Inhibitor
Gaofei Lu, PhD, Emory University
Necrotizing Acute Acalculous Cholecystitis and Zika Virus Infection in an Immunocompromised Individual with Gilbert Syndrome
Suzane Kioko Ono, MD, PhD, University of São Paulo
A Novel Cell Based Antiviral Assay for Zika Virus
Raj Kalkeri, MBA, Southern Research
Development of Immunological Countermeasures for Zika Virus
Luke Robinson, Visterra, Inc.
Development of Zika Vaccine
Farshad Guirakhoo, PhD, GeoVax, Inc
ANTIVIRAL AGENTS SESSION
Chairs:
Jorge Kalil, MD, PhD
Baek Kim, PhD
State-of-the-Art Lecture:
Anti-Inflammatory Drugs for Zika Virus and Other Flaviviruses
Mauro Martins Teixeira, PhD
Biological and Virological Properties of Brazilian Zika Virus Isolates
Amilcar Tanuri, MD, PhD
Predicting the Structural Biology of Zika Virus—Challenges and Targets for Intervention
Bryan Cox, PhD
IMMUNOLOGY, DIAGNOSIS, & ECOLOGY SESSION
Chairs:
Scott Weaver, MS, PhD
Paolo Marinho de Andrade Zanotto, PhD
State-of-the-Art Lecture:
Vaccines and Monoclonal Antibody Treatments for Zika
David Watkins, PhD
Strategies to Develop Antibodies and Vaccines to Fight Zika Virus
Jorge Kalil, MD, PhD
Innate Immune Control of Zika Virus Infection
Mehul Suthar, PhD
Using Dengue Virus to Understand the Spatial Dimension of Zika Surveillance, Transmission, and Control
Gonzalo Vazquez-Prokopec, PhD
Round Table Discussion With Expert Panel and Audience
Sex Transmission and Mosquitoes: A New Phenomenon in Arbovirology?
Leaders:
Panel:
Carlos del Rio, MD
José Esparza, MD, PhD
Jorge Kalil, MD, PhD
Glaucius Oliva, PhD
Timothy Tellinghuisen, PhD
Mauro Martins Teixeira, PhD
Maria Van Kerkhove, PhD
Gonzalo Vazquez-Prokopec, PhD
David Watkins, PhD
Scott Weaver, MS, PhD
Paolo Marinho de Andrade Zanotto, PhD
Closing Remarks Raymond Schinazi, PhD, DSc
Happy Hour
Tuesday, May 3, 2016
MORNING SESSION (optional)
Public Forum and Press
José Esparza, MD, PhD
Mauro Martins Teixeira, PhD
Glaucius Oliva, PhD
Raymond Schinazi, PhD, DSc
Scott Weaver, MS, PhD
Guidelines for Submitting an Abstract
You are asked to follow these guidelines when submitting an abstract, and upload your abstract during the registration process.
- Please note that abstract submission is part of the registration process. Therefore, abstract submission cannot be done without registering for meeting attendance.
- The abstract committee will decide which abstracts will be accepted, and also which abstracts are selected for oral presentations.
- Should your abstract not be accepted by the abstract review committee, then you are entitled to have your registration fee refunded. Please send a request for refund to Jaye.Harden@prIMEoncology.org.
- At least one of the authors of the accepted abstract MUST attend the meeting and present the abstract.
- Abstract submission deadline is 11.00 PM US Eastern Time, on Monday, April 18, 2016
Categories:
- Epidemiology
- Pathogenesis – human and animal
- Antiviral agent development
- Vaccine development
- Animal models
- Differential diagnostics
- Mosquito control
Requirements:
- Abstracts must contain recent, unpublished information
- Abstract must be written in English
- Abstracts will not be edited once submitted
- Requested filename: <<abstractZika_2016_LAST NAME_FIRST INITIALS of the first author>>
eg, : <<abstractZika_2016_JOHANSSON_FKT>> - The abstract title should be as concise as possible; should appear in bold, lowercase font; and should be centered
- Main body of text to be left aligned
- Abstract should be sent as a Microsoft Word document; single‐spaced throughout the abstract; typed in lowercase Arial font size 11
- List affiliations of author(s) in the abstract as briefly as possible, eg:
Author(s):
A. Author, 1,2, B . Author, 1, C. Author, 2
1. Institution Name, City, (State if USA), Country
2. Institution Name, City, (State if USA), Country - Place an asterisk (*) after the senior author and underline the name of the presenting author. Once accepted, presenting author cannot be substituted without permission from the organizer.
- There is no maximum word count for the abstract, but the abstract should be concise
- All accepted abstracts will be presented in an oral format; the presentation should be limited to 6 slides including the title slide; and the talk should be given in under 8 minutes, with a maximum of 2 minutes for questions
- References, cited with superscripted numbers in the text, should be listed at the end of the text using standard and well accepted formats
- The use of figures, graphs, and schemes is recommended when they aid in the understanding of the text
- Please include the full address and contact details of the main author and the presenting author, and indicate whether you are submitting an oral or a poster presentation (can be indicated on online registration form)
- Use standard, well accepted abbreviations
- Abstract should contain the following subheads:
- Purpose of the study
- Methods/summarized description of the project
- Results
- Conclusions
- Data presented at other meetings is acceptable, but if the presentation was made at an international meeting of more than 100 attendees, please indicate in the abstract that part or all of the material has also been presented, and the name and date of the meeting
Please contact us at Jaye.Harden@prIMEoncology.org or telephone +1 678.892.1353 if you have any questions.
Exhibitor Information
$2500 Exhibitor Package includes:
- One draped 6’ table with (2) chairs
- Registration and name badges for two (2) company representatives to exhibit and attend the educational sessions
- Breakfast, breaks, lunch, and receptions for two (2) company representatives
- Post-meeting list of attendees (name, city, state)
Additional representatives may attend for $560 each.
Exhibitor Registration
Online registration is now available. The name and email addresses of both representatives attending are required fields. Payment can be made by check or online by credit card.
PLEASE NOTE: If you choose to pay online via credit card, you will incur a 4.95% processing fee.
For payment by check, please make checks payable to PLATO Foundation
Tax ID # 27-2320951 for the designated amount and send by overnight mail to:
PLATO Foundation
Two Concourse Parkway, Suite 260
Atlanta, GA 30328
Attention: Jaye Harden – Zika Conference
For questions or further information, please contact Jaye Harden, 678.892.1353 or Jaye.Harden@prIMEoncology.org
Shipping to the Venue
If you are shipping materials to the hotel, please number each box in your shipment (eg, Box 1 of 3) and address packages as follows:
Your Name & Company’s Name
c/o Jaye Harden
Emory Conference Center Hotel
1615 Clifton Road NE, Atlanta, GA 30329
ATTN: Zika Virus Conference, May 1-2, 2016